Currently out of the existing stock ratings of Greg Chodaczek, 1 are a BUY (100%).

Greg Chodaczek

Work Performance Price Targets & Ratings Chart

Analyst Greg Chodaczek, carries an average stock price target met ratio of 100% that have a potential upside of 97.45% achieved within 2327 days. Previously, Greg Chodaczek worked at B. RILEY.

Greg Chodaczek’s has documented 1 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ADMP, Adamis Pharma at 20-Dec-2016.

Wall Street Analyst Greg Chodaczek

Analyst best performing recommendations are on ADMP (ADAMIS PHARMA).

Average potential price target upside

ADMP Adamis Pharma NVRO Nevro Corp TNDM Tandem Diabetes Care

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 22-Mar-2022

4 years 4 months 8 days ago
(19-May-2022)

4/4 (100%)

$-43.45 (-97.75%)

1702

Hold Since 16-Nov-2020

$1.5

5 years 10 months 11 days ago
(16-Nov-2020)

2/2 (100%)

$-38.7 (-96.27%)

1340

Hold Since 26-Nov-2019

6 years 10 months 1 days ago
(26-Nov-2019)

1/1 (100%)

$-364 (-98.11%)

2030

$5

$4.51 (920.41%)

9 years 9 months 7 days ago
(20-Dec-2016)

1/1 (100%)

$-191 (-97.45%)

2327

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?